Planta Med 2002; 68(5): 416-419
DOI: 10.1055/s-2002-32087
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

In Vitro Antimycobacterial and Antilegionella Activity of Licochalcone A from Chinese Licorice Roots

Alice Friis-Møller1 , Ming Chen2 , Kurt Fuursted3 , Søren Brøgger Christensen4 , Arsalan Kharazmi2
  • 1Department of Clinical Microbiology, Hvidovre Hospital, Copenhagen, Denmark
  • 2Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
  • 3Statens Serum Institut, Copenhagen, and Department of Clinical Microbiology, Aarhus,Denmark
  • 4Department of Medicinal Chemistry, Royal Danish School of Pharmacy, Copenhagen, Denmark
Further Information

Publication History

July 10, 2001

December 2, 2001

Publication Date:
07 June 2002 (online)

Abstract

Licochalcone A, extracted and purified from Chinese licorice roots, showed in vitro inhibitory effect on human pathogenic Mycobacteria species and Legionella species. M. tuberculosis, M. bovis and BCG were inhibited by < 20 mg/l licochalcone A, whereas all non-M. tuberculosis complex species were resistant to > 20 mg/l Legionella pneumophila (serogroups 1 - 7) and L. bozemanii, L. dumoffii, L. feelei, L. longbeacheae and L. wadsworthii were inhibited by licochalcone A 1 - 4 mg/l, whereas L. gormanii and L. micdadei were inhibited by licochalcone A 500 - 1000 mg/l. These data indicate that licochalcone A might be of interest as a new class of antibacterial drug in the treatment of severe lung-infections.

References

  • 1 Sheng L H. Traditional Chinese medicine and immunity. Guangdong Scientific Publishing House, Guangzhou, People’s Republic of China 1982: 41-9
  • 2 Jun R, Wang Z. Pharmacological research on the effect of licorice.  Journal of Traditional Chinese Medicine. 1988;  3 307-9
  • 3 Yang L, Liu Y L, Lin S Q. HPLC analysis of flavonoids in the root of six Glycyrrhiza species.  Acta Pharmaceutica Sinica. 1990;  25 840-8
  • 4 Hatano T, Kagawa H, Yasuhara T, Okuda T. Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects.  Chemical and Pharmaceutical Bulletin. 1988;  36 2090-7
  • 5 Shibata S, Inoue H, Iwata S, Ma R, Yu L, Ueyama H, Takayasu J, Hasegawa T, Tokuda H, Nishino A, Nishino H, Iwashima A. Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice.  Planta Medica. 1991;  57 221-4
  • 6 Shibata S. Anti-tumorigenic Chalcones.  Stem Cells. 1994;  12 44-52
  • 7 Okada K, Tamura Y, Yamamoto M, Inoue Y, Takagaki R, Takahashi K, Demizu S, Kajiyama K, Hiraga Y, Kinoshita T. Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang Origin.  Chemical and Pharmaceutical Bulletin. 1989;  37 2528-30
  • 8 Rafi M, Rosen R T, Vassil A ., Ho C T, Zhang H, Ghai G, Lambert G, Dipaola R S. Modulation of bcl-2 and cytotoxicity by licochalcone A, a novel estrogenic flavonoid.  Anticancer Research. 2000;  20 2653-8
  • 9 Christensen S B, Chen M, Andersen L, Hjørne U, Olsen C E, Cornett C, Theander T G, Kharazmi A. An atileishmanial calcone from Chinese licorice roots.  Planta Medica. 1994;  60 121-3
  • 10 Chen M, Christensen S B, Theander T G, Kharazmi A. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani .  Antimicrobial Agents and Chemotherapy. 1994;  8 339-44
  • 11 Chen M, Theander T G, Christensen S B, Hviid L, Zhai L, Kharazmi A. Licochalcone A, a new antimalarial agent inhibits the in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii Infection.  Antimicrobial Agents and Chemotherapy. 1994;  38 1470-5
  • 12 Grange J M. Tuberculosis. In: Topley & Wilson’s Microbiology and Microbial Infections, Hausler Jr. WJ, Sussman M, editors Bacterial Infections, Vol 3. Arnold,. 1998: pp. 391-417
  • 13 Read R C, Finch R G. Bacterial Infections of the Respiratory Tract. In: Topley & Wilson’s Microbiology and Microbial Infections, Hausler Jr. WJ, Sussman M, editors Bacterial Infections, Vol 3. Arnold,. 1998: pp. 329-31
  • 14 Pablos-Mendez A, Raviglione M C, Laszlo A, Binkin N, Rieder H L, Bustreo F, Cohn D L, Lambregts-van Weezenbeek C SB, Kim S J, Chaulet P, Nunn P. Global surveillance for antituberculosis-drug resistance, 1994 - 1997.  New England Journal of Medicine. 1998;  338 1641-9
  • 15 Escalante P, Graviss E A, Griffith D E, Musser J M, Awe R J. Treatment of isoniazid-resistant tuberculosis in southeastern Texas.  Chest.. 2001;  119 1730-6
  • 16 Edelstein P H. Legionnaires’ disease.  Clinical Infectious Diseases. 1993;  16 741-9
  • 17 Fraser D W. Sources of legionellosis. In: Thornsberry C, Balows A, Feeley JC, Jakubowski W. (eds) Legionella, Proceedings of the 2nd International Symposium. Washington, DC; American Society for Microbiology 1984: 277-80
  • 18 Fields B S. The molecular ecology of legionellae.  Trends in Microbiology. 1996;  4 286-90
  • 19 Hebert G A, Callaway C S, Ewing E P. Comparison of Legionella pneumophila, L. micdadei, L. bozemanii and L. dumoffii by transmission electron microscopy.  Journal of Clinical Microbiology. 1984;  19 116-21
  • 20 Chen M, Zhai L, Christensen S B, Theander T G, Kharazmi A. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones.  Antimicrobial Agents and Chemotherapy. 2001;  45 2023-9

Alice Friis-Møller,M.D. 

Department of Clinical Microbiology

Hvidovre Hospital

Kettegård Alle 30

2650 Hvidovre

Denmark

Email: alice.friis-moeller@hh.hosp.dk

Phone: +45 36 32 24 11

Fax: +45 36 32 33 57

    >